Design and synthesis of orally available MEK inhibitors with potent in vivo antitumor efficacy

The MAPK signaling cascade

Rony Seger, Edwin G. Krebs · The FASEB Journal · 1995 · 3.4K citations

Life Sciences, Cell Biology, Molecular Biology +17

^V600E BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway

Christine A. Pratilas, Barry S. Taylor, Qing Ye et al. · Proceedings of the National Academy of Sciences · 2009 · 614 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Basal Subtype and MAPK/ERK Kinase (MEK)-Phosphoinositide 3-Kinase Feedback Signaling Determine Susceptibility of Breast Cancer Cells to MEK Inhibition

Olga K. Mirzoeva, Debopriya Das, Laura M. Heiser et al. · Cancer Research · 2009 · 389 citations · Full text

Medicine, Cancer Biology, Oncology +17

The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901

Stephen D. Barrett, Alexander J. Bridges, David T. Dudley et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 286 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9

Targeting Mitogen-Activated Protein Kinase/Extracellular Signal–Regulated Kinase Kinase in the Mutant (V600E) B-Raf Signaling Cascade Effectively Inhibits Melanoma Lung Metastases

Arati Sharma, Melissa Tran, Shile Liang et al. · Cancer Research · 2006 · 111 citations · Full text

Medicine, Cancer Biology, Oncology +17